Monitoring lifestyle and physical fitness in China's working population
Official title: Effects of Lifestyle and Physical Fitness on Cardiovascular Health: a Cohort Study in Chinese Occupational Population
Run by China National Center for Cardiovascular Diseases · NCT06275009 · Data updated 2026-11-12
This study is tracking the health and lifestyle habits of working people in China to see how these factors affect heart health over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 18512 (estimated) |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 11, 2023 |
| Main results expected | December 11, 2026 |
| Study ends | December 11, 2026 |
| Registry record updated | February 28, 2024 |
| Trial ID | NCT06275009 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-59 who are part of the occupational workforce and willing to participate in long-term follow-up.
✕Probably not a fit
Patients with a history of cardiovascular diseases, cancer, or severe congenital conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a cohort of occupational individuals in China to monitor lifestyle factors and physical fitness related to cardiovascular health. It will track the incidence of metabolic risk factors such as obesity, hypertension, diabetes, and cardiovascular diseases among participants aged 18-59. The study will assess various lifestyle aspects, including diet, physical activity, smoking, and psychological stress, to understand their impact on cardiovascular health over time. Participants will be followed long-term to gather comprehensive data on these interactions.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for preventing cardiovascular diseases in the occupational population.
How similar studies have gone: While similar cohort studies have been conducted, this specific focus on the occupational population in China presents a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adults between 18-59 years of age * occupational staff * willing to accept long-term follow-up Exclusion Criteria: * participants with previous CVD history such as myocardial infarction, stroke and severe aortic stenosis; * with cancer; * with congenital genetic diseases, or cannot cooperate with the investigation and follow-up due to acquired diseases, such as congenital heart disease, paralysis, deafness, dementia, mental abnormality, developmental retardation, etc.; * with exercise contraindications; * duration of pregnancy; * refuse to sign the informed consent.
Where it's running
-
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Hongyi Du, MD PhD
- Email: duhy@bjmu.edu.cn
- Phone: 86-10-88396087
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring how lifestyle factors relate to cardiovascular health
This study looks at how things like exercise, stress, and diet affect heart health in both adults and children.
-
Understanding health trends in Puerto Rico
This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.